Vanguard Fiduciary Trust
ALT icon

Vanguard Fiduciary Trust’s Altimmune ALT Stock Holding History

Vanguard Fiduciary Trust’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.93M Buy
1,293,001
+423,683
+49% +$1.27M ﹤0.01% 2326
2026
Q1 		$2.68M Buy
+869,318
New +$3.69M ﹤0.01% 2415

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust's ALT Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Altimmune (ALT) stake by 49% in Q2 2026, buying an estimated $1.27M and bringing the position to 1,293,001 shares worth $3.93M. The position accounts for ﹤0.01% of the portfolio, ranked #2326.

Vanguard Fiduciary Trust first reported a position in ALT in Q1 2026 and has held it in 2 quarters since. 208 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Vanguard Fiduciary Trust held 1,293,001 shares of Altimmune worth $3.93M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 423,683 Altimmune shares in Q2 2026, an estimated $1.27M.
  • Altimmune made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #2326 holding.
  • Vanguard Fiduciary Trust first reported a position in Altimmune in Q1 2026 and has held it in 2 quarters since.
  • 208 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.